Bangkok Dusit Medical Services Public Company Limited
BDULF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.83 | -1.24 | 0.00 | 0.00 |
| FCF Yield | 1.04% | 0.80% | 1.16% | 0.12% |
| EV / EBITDA | 46.51 | 53.31 | 52.71 | 67.97 |
| Quality | ||||
| ROIC | 3.31% | 2.73% | 3.32% | 3.33% |
| Gross Margin | 37.00% | 35.14% | 37.02% | 37.83% |
| Cash Conversion Ratio | 1.16 | 1.14 | 1.39 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.08% | 5.03% | 5.56% | 5.47% |
| Free Cash Flow Growth | 32.02% | -41.92% | 683.97% | -82.92% |
| Safety | ||||
| Net Debt / EBITDA | 1.78 | 1.79 | 0.94 | 1.57 |
| Interest Coverage | 68.75 | 46.73 | 57.90 | 49.36 |
| Efficiency | ||||
| Inventory Turnover | 5.85 | 5.93 | 6.31 | 6.54 |
| Cash Conversion Cycle | 16.51 | 18.90 | 17.81 | 26.92 |